Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Miller

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|January 31, 2017
ABM Clinical Protocol #27: Breastfeeding an Infant or Young Child with Insulin-Dependent DiabetesDiana Miller, Leena Mamilly, Shannon Fourtner, et al.
Pain Medicine (Malden, Mass.)|July 15, 2009
Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind studyDiana Miller, Diana Richardson, Mahmood Eisa, et al.
Diabetes Technology & Therapeutics|March 23, 2018
Sensor-Augmented Pump-Based Customized Mathematical Model for Type 1 DiabetesBenyamin Grosman, Di Wu, Diana Miller, et al.
Human Molecular Genetics|January 5, 2018
Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix depositionLeelamma M Panicker, Manasa P Srikanth, Thiago Castro-Gomes, et al.
Human Molecular Genetics|July 30, 2015
Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cellsOla Awad, Chinmoy Sarkar, Leelamma M Panicker, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2026
Pharmacology and nonclinical development of teplizumab, a first-in-class immunotherapy for delaying the onset of type 1 diabetesRao N V S Mamidi, Mark Peakman, Wolfgang Schmider, et al.
Stem Cells (Dayton, Ohio)|May 8, 2014
Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic developmentLeelamma M Panicker, Diana Miller, Ola Awad, et al.
Stem Cells Translational Medicine|June 12, 2015
Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant MyelopoiesisJudi A Sgambato, Tea Soon Park, Diana Miller, et al.
Diabetes Technology & Therapeutics|February 28, 2024
An Automated Insulin Delivery System with Automatic Meal Bolus Based on a Hand-Gesturing AlgorithmAnirban Roy, Benyamin Grosman, Andrea Benedetti, et al.
Diabetes Technology & Therapeutics|April 13, 2026
MiniMed<sup><b>™</b></sup> 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic DisadvantageMargaret Liu, Fang Niu, Caroline Yovanovich, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|January 31, 2017
ABM Clinical Protocol #27: Breastfeeding an Infant or Young Child with Insulin-Dependent DiabetesDiana Miller, Leena Mamilly, Shannon Fourtner, et al.
Pain Medicine (Malden, Mass.)|July 15, 2009
Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind studyDiana Miller, Diana Richardson, Mahmood Eisa, et al.
Diabetes Technology & Therapeutics|March 23, 2018
Sensor-Augmented Pump-Based Customized Mathematical Model for Type 1 DiabetesBenyamin Grosman, Di Wu, Diana Miller, et al.
Human Molecular Genetics|January 5, 2018
Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix depositionLeelamma M Panicker, Manasa P Srikanth, Thiago Castro-Gomes, et al.
Human Molecular Genetics|July 30, 2015
Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cellsOla Awad, Chinmoy Sarkar, Leelamma M Panicker, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2026
Pharmacology and nonclinical development of teplizumab, a first-in-class immunotherapy for delaying the onset of type 1 diabetesRao N V S Mamidi, Mark Peakman, Wolfgang Schmider, et al.
Stem Cells (Dayton, Ohio)|May 8, 2014
Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic developmentLeelamma M Panicker, Diana Miller, Ola Awad, et al.
Stem Cells Translational Medicine|June 12, 2015
Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant MyelopoiesisJudi A Sgambato, Tea Soon Park, Diana Miller, et al.
Diabetes Technology & Therapeutics|February 28, 2024
An Automated Insulin Delivery System with Automatic Meal Bolus Based on a Hand-Gesturing AlgorithmAnirban Roy, Benyamin Grosman, Andrea Benedetti, et al.
Diabetes Technology & Therapeutics|April 13, 2026
MiniMed<sup><b>™</b></sup> 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic DisadvantageMargaret Liu, Fang Niu, Caroline Yovanovich, et al.
Pageof 2